SMAD2 and breast cancer: Our observations are further supported by others showing that TGF-β-induced smad2/3 blocks the CXCL1 promoter in fibroblasts [39,40], and the expression of breast cancer stromal CXCL1 is inversely correlated with the expression of TGF-β signaling [40].